News Announcement

SMS Pharmaceuticals: Announcement Under Regulation 30 - Investments In Subsidiary Company By Way Of Subscription Towards Rights Issue

Investment in Subsidiary Company by way of subscription towards right issue.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.